Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Aurélie Moniot"'
Autor:
Aurélie Moniot, Christophe Schneider, Laure Chardin, Elisa Yaniz-Galende, Catherine Genestie, Marion Etiennot, Aubéri Henry, Coralie Drelon, Audrey Le Formal, Benoit Langlois, Laurence Venat, Christophe Louvet, Laure Favier, Alain Lortholary, Dominique Berton-Rigaud, Nadine Dohollou, Christophe Desauw, Michel Fabbro, Emmanuelle Malaurie, Coraline Dubot, Jean Emmanuel Kurtz, Nathalie Bonichon Lamichhane, Éric Pujade-Lauraine, Albin Jeanne, Alexandra Leary, Stéphane Dedieu
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract Background Ovarian cancer (OC) remains one of the most challenging and deadly malignancies facing women today. While PARP inhibitors (PARPis) have transformed the treatment landscape for women with advanced OC, many patients will relapse and
Externí odkaz:
https://doaj.org/article/dd3b485e8ca3415e9aedea04cb9e8214
Autor:
Aurélie Moniot, Julien Braux, Christine Guillaume, Ingrid Allart-Simon, Sandra Audonnet, Sarah Renault, Françoise Rédini, Janos Sapi, Sophie C. Gangloff, Stéphane Gérard, Frédéric Velard
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100682- (2020)
Externí odkaz:
https://doaj.org/article/78904c357ce042e0a092282fe45966e0
Autor:
Hassan Rammal, Laura Entz, Marie Dubus, Aurélie Moniot, Nicolae B. Bercu, Johan Sergheraert, Sophie C. Gangloff, Cédric Mauprivez, Halima Kerdjoudj
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 7 (2019)
While stem cell/biomaterial studies provide solid evidences that biomaterial intrinsic cues deeply affect cell fate, current strategies tend to neglect their effects on mesenchymal stem cells (MSCs) secretory activities and resulting cell-crosstalks.
Externí odkaz:
https://doaj.org/article/df4f48d6f73345d591c94f40945adb27
Autor:
Velard, Aurélie Moniot, Julien Braux, Renaud Siboni, Christine Guillaume, Sandra Audonnet, Ingrid Allart-Simon, Janos Sapi, Rabindra Tirouvanziam, Stéphane Gérard, Sophie C. Gangloff, Frédéric
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 13; Pages: 7226
In inflammatory diseases, polymorphonuclear neutrophils (PMNs) are known to produce elevated levels of pro-inflammatory cytokines and proteases. To limit ensuing exacerbated cell responses and tissue damage, novel therapeutic agents are sought. 4aa a
Autor:
Aurélie, Moniot, Julien, Braux, Renaud, Siboni, Christine, Guillaume, Sandra, Audonnet, Ingrid, Allart-Simon, Janos, Sapi, Rabindra, Tirouvanziam, Stéphane, Gérard, Sophie C, Gangloff, Frédéric, Velard
Publikováno v:
International journal of molecular sciences. 23(13)
In inflammatory diseases, polymorphonuclear neutrophils (PMNs) are known to produce elevated levels of pro-inflammatory cytokines and proteases. To limit ensuing exacerbated cell responses and tissue damage, novel therapeutic agents are sought. 4aa a
Autor:
Aurélie Moniot, Françoise Rédini, Frédéric Velard, Janos Sapi, Sarah Renault, Camille Bour, Sandra Audonnet, Ingrid Allart-Simon, Julien Braux, Fabien Lamret, Christine Guillaume, Sophie C. Gangloff, Marie Laronze-Cochard, Stéphane Gérard
Publikováno v:
Cancers
Cancers, 2021, 13, ⟨10.3390/cancers13235992⟩
Cancers, MDPI, 2021, 13, ⟨10.3390/cancers13235992⟩
Cancers, Vol 13, Iss 5992, p 5992 (2021)
Cancers; Volume 13; Issue 23; Pages: 5992
Cancers, 2021, 13, ⟨10.3390/cancers13235992⟩
Cancers, MDPI, 2021, 13, ⟨10.3390/cancers13235992⟩
Cancers, Vol 13, Iss 5992, p 5992 (2021)
Cancers; Volume 13; Issue 23; Pages: 5992
Simple Summary There is a dire need for novel therapeutic interventions to treat osteosarcoma. Pyridazinone derivatives have proven some efficacy in several cancer models, but their effect on osteosarcoma is yet to be evaluated. Our goal was to synth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3db30ba196521431e36c56fd65be938
https://hal.univ-reims.fr/hal-03455578/document
https://hal.univ-reims.fr/hal-03455578/document
Autor:
Frédéric Velard, Nicolo Bisi, Janos Sapi, Sandra Audonnet, Aurélie Moniot, Stéphane Gérard, Marie Laronze-Cochard, Eric Hénon, Ingrid Allart-Simon, Miguel Ponce-Vargas
Publikováno v:
RSC Medicinal Chemistry
RSC Medicinal Chemistry, Royal Society of Chemistry, 2021, 12, pp.584-592. ⟨10.1039/d0md00423e⟩
RSC Med Chem
RSC Medicinal Chemistry, Royal Society of Chemistry, 2021, 12, pp.584-592. ⟨10.1039/d0md00423e⟩
RSC Med Chem
International audience; Cyclic nucleotide phosphodiesterase type 4 (PDE4), which controls the intracellular level of cyclic adenosine monophosphate (cAMP), has aroused scientific attention as a suitable target for antiinflammatory therapy of respirat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713631ad5f71ac378605bffc82252434
https://hal.archives-ouvertes.fr/hal-03352041
https://hal.archives-ouvertes.fr/hal-03352041
Autor:
Ingrid Allart-Simon, Julien Braux, Aurélie Moniot, Frédéric Velard, Janos Sapi, Christine Guillaume, Stéphane Gérard, Sophie C. Gangloff, Françoise Rédini, Sandra Audonnet, Sarah Renault
Publikováno v:
Bone Reports, Vol 13, Iss, Pp 100682-(2020)
Autor:
Laurette Malleret, Janos Sapi, Chantal Barberot, Ingrid Allart-Simon, Jean-Philippe Bouillon, Aurélie Moniot, Frédéric Velard, Marie Laronze-Cochard, Eric Hénon, Maurice Médebielle, Stéphane Gérard, Abderrazzaq Bentaher, Tatiana Yegorova
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2018, 146, pp.139-146. ⟨10.1016/j.ejmech.2018.01.035⟩
European Journal of Medicinal Chemistry, 2018, 146, pp.139-146. ⟨10.1016/j.ejmech.2018.01.035⟩
European Journal of Medicinal Chemistry, Elsevier, 2018, 146, pp.139-146. ⟨10.1016/j.ejmech.2018.01.035⟩
European Journal of Medicinal Chemistry, 2018, 146, pp.139-146. ⟨10.1016/j.ejmech.2018.01.035⟩
International audience; Cyclic nucleotide phosphodiesterase type 4 (PDE4), that controls intracellular level of cyclic nucleotide cAMP, has aroused scientific attention as a suitable target for anti-inflammatory therapy in respiratory diseases. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63c04fdaba7f3c4e667ea748cea6720
https://hal-normandie-univ.archives-ouvertes.fr/hal-02024470
https://hal-normandie-univ.archives-ouvertes.fr/hal-02024470
Autor:
Moniot, Aurélie1 (AUTHOR), Schneider, Christophe2 (AUTHOR), Chardin, Laure3 (AUTHOR), Yaniz-Galende, Elisa3 (AUTHOR), Genestie, Catherine3 (AUTHOR), Etiennot, Marion1 (AUTHOR), Henry, Aubéri1 (AUTHOR), Drelon, Coralie2 (AUTHOR), Le Formal, Audrey3 (AUTHOR), Langlois, Benoit2 (AUTHOR), Venat, Laurence4 (AUTHOR), Louvet, Christophe5 (AUTHOR), Favier, Laure6 (AUTHOR), Lortholary, Alain7 (AUTHOR), Berton-Rigaud, Dominique8 (AUTHOR), Dohollou, Nadine9 (AUTHOR), Desauw, Christophe10 (AUTHOR), Fabbro, Michel11 (AUTHOR), Malaurie, Emmanuelle12 (AUTHOR), Dubot, Coraline13 (AUTHOR)
Publikováno v:
Molecular Cancer. 8/14/2024, Vol. 23 Issue 1, p1-17. 17p.